BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sterion Sells Medical Product Business To Aspen Surgical Products


10/19/2005 5:12:08 PM

MINNEAPOLIS, Nov. 8 /PRNewswire-FirstCall/ -- Sterion Incorporated today announced that the company has sold its medical product business located in Ham Lake, Minnesota to Grand Rapids, Michigan based Aspen Surgical Products for $6.5 million in cash and notes. The company expects to realize a pretax gain of approximately $.75 per share in its second fiscal quarter ending December 31, 2004. In addition, the agreement calls for certain contingent payments based upon future performance of the business. The businesses included in the sale includes the Company's disposable operating room support products, private-label manufacturing, and the Surgidyne brand of surgical wound drainage products. Aspen also acquired the Sterion, Oxboro and Surgidyne brand names. The Company will provide Aspen with transitional manufacturing services for these products for a short period following the closing of the sale.

The company also announced that its board of directors has authorized a new share repurchase plan covering 175,000 shares. These shares may be repurchased from time to time as market conditions permit.

The sale reflects Sterion's strategic decision to focus its management attention and resources on businesses it believes will provide significant opportunities to grow value for its shareholders, including its LifeSafe and Burger Time business units.

About Sterion

Sterion Incorporated, headquartered in Minnesota, is a diversified business. Through LifeSafe Services, the Company provides business customers emergency oxygen equipment and related products and services. On July 1, 2004 the Company acquired an 11-unit chain of fast-food, drive-through restaurants operated under the Burger Time name. The Company also provides contract manufacturing services for surgical instrument sterilization container systems. With the sale to Aspen Surgical Products, the Company has disposed of the business units historically included in its medical products group composed of disposable operating room support products, private-label manufacturing, and the Surgidyne brand of surgical wound drainage products.

About Aspen Surgical Products

Aspen Surgical is a privately held company based in Grand Rapids, Michigan. The company is a leading manufacturer of disposable medical products focusing on the operating room environment. Aspen Surgical currently sells its products to over 5000 U.S. hospitals and in 40 countries worldwide.

Sterion Incorporated common stock is traded on the Nasdaq SmallCap Market under the symbol STEN. More information about Sterion is available at the Company's website: http://www.sterion.com/ . Except for historical information contained herein, the disclosures in this news release are forward-looking statements that could be affected by certain risks and uncertainties, and actual results may differ materially, depending on a variety of factors. These risks are described in the Company's Annual Report on Form 10-KSB for the year ended September 30, 2003 and other filings with the Securities and Exchange Commission. The Company undertakes no duty or obligation to update any of the forward-looking statements after the date of this release.

Sterion Incorporated

CONTACT: Kenneth W. Brimmer, President of Sterion Incorporated,+1-763-755-9516



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES